In immunoblot analysis of a panel of breast cancer cell lines, we observed that the protein content and phosphorylation status of c-MET were relatively higher in TNBC when compared to luminal or HER2-positive subtypes (Fig. 2C). This evidence concerns the gene ERBB2 and breast carcinoma.